Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have received a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $21.60.

A number of equities research analysts recently issued reports on the stock. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Cantor Fitzgerald lifted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Tuesday. Truist Financial upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Finally, Citizens Jmp boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors have recently bought and sold shares of the business. PNC Financial Services Group Inc. raised its stake in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares during the period. Larson Financial Group LLC boosted its position in Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the period. Anchor Investment Management LLC increased its holdings in Sabra Healthcare REIT by 15.5% in the 3rd quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock valued at $77,000 after purchasing an additional 556 shares in the last quarter. Inspire Investing LLC raised its position in Sabra Healthcare REIT by 2.3% in the fourth quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock valued at $469,000 after purchasing an additional 565 shares during the period. Finally, Oppenheimer & Co. Inc. raised its position in Sabra Healthcare REIT by 1.7% in the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock valued at $633,000 after purchasing an additional 581 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA opened at $20.03 on Thursday. The company has a market cap of $5.05 billion, a P/E ratio of 31.30, a P/E/G ratio of 1.45 and a beta of 0.67. The business has a fifty day simple moving average of $19.10 and a 200-day simple moving average of $18.81. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.70. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same period in the previous year, the business posted $0.36 earnings per share. The firm’s quarterly revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.